Jean Jeunesse

USPTO Granted Patents = 7 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 114(Granted Patents)

Location History:

Champigny sur Marne, FR (2001)
Paris, FR (2002 - 2014)

Company Filing History:

Years Active: 2001-2014

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8835418 - Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application (2014-09-16),

2. 8034818 - Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates (2011-10-11),

3. 7781590 - Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors (2010-08-24),

4. 7214798 - Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics (2007-05-08),

5. 6635645 - 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses (2003-10-21),

6. 6407095 - 1,4-diazabicylo[3,2,2]nonane derivatives, their preparation and their therapeutic application (2002-06-18),

7. 6248757 - 3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands (2001-06-19),

Title: The Innovative Contributions of Jean Jeunesse

Introduction

Jean Jeunesse is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the development of therapeutic compounds. With a total of 7 patents to his name, his work has had a considerable impact on pharmaceutical research and development.

Latest Patents

Among his latest patents, Jean Jeunesse has developed hexafluoroisopropyl carbamate derivatives, which have therapeutic applications. The disclosure relates to these derivatives of general formula (I), showcasing their potential in medical treatments. Additionally, he has explored the therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates, which also correspond to a specific general formula (I). These innovations highlight his commitment to advancing therapeutic options in medicine.

Career Highlights

Throughout his career, Jean Jeunesse has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Sanofi-Aventis. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic applications.

Collaborations

Jean Jeunesse has collaborated with esteemed colleagues such as Christian Hoornaert and Alistair Lochead. These partnerships have further enriched his research and innovation efforts in the field.

Conclusion

Jean Jeunesse's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his dedication to improving therapeutic options for patients. His work continues to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.